LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

AZN

188.47

+3.03%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

AZN

188.47

+3.03%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

AZN

188.47

+3.03%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

AZN

188.47

+3.03%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

AZN

188.47

+3.03%↑

Home・Akcijų sąrašas・Ventyx Biosciences Inc

Ventyx Biosciences Inc

Uždarymo kaina

13.99

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

13.99

Max

13.99

Pagrindiniai rodikliai
By Trading Economics
Pajamos	4.2M -23M
Darbuotojai	83
EBITDA	6.6M -23M

Rekomendacijos
By TipRanks
Rekomendacijos	Neutralu
12 mėnesių prognozė	-4.43% downside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	418M 1B
Ankstesnė atidarymo kaina	13.99
Ankstesnė uždarymo kaina	13.99

Ventyx Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-12 23:12; UTC

Karštos akcijos

Stocks to Watch: Adobe, Mission Produce, Buzzfeed, Ulta

2026-03-12 22:15; UTC

Uždarbis

Wheaton Precious Metals Logs Higher 4Q Net Income, Boosts Dividend 18%

2026-03-12 21:42; UTC

Svarbiausios naujienos

Stryker Says Cyberattack Disruption Is Continuing

2026-03-12 21:29; UTC

Svarbiausios naujienos

Correction to War in Iran May Upend Brazil Central Bank's Plans Article

2026-03-12 21:27; UTC

Uždarbis

Adobe CEO to Depart as AI Boosts Sales -- Update

2026-03-12 20:46; UTC

Uždarbis

Adobe Posts Higher Sales With CEO Set to Depart

2026-03-12 20:21; UTC

Svarbiausios naujienos

Soybean Futures Higher on Instability in Iran --Daily Grain Highlights

2026-03-12 23:57; UTC

Rinkos pokalbiai

Gold Edges Higher Amid Ongoing Middle East Conflict -- Market Talk

2026-03-12 23:38; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-12 23:38; UTC

Rinkos pokalbiai

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

2026-03-12 22:13; UTC

Uždarbis

Orient Overseas: Tariff Measures, Trade Tensions Weighed on Results >0316.HK

2026-03-12 22:13; UTC

Uždarbis

Orient Overseas: Middle East Situation Have Added to Future Uncertainity >0316.HK

2026-03-12 22:13; UTC

Uždarbis

Orient Overseas: Charter Market Remains Exceptionally Tight With Vessels in Short Supply >0316.HK

2026-03-12 22:13; UTC

Uždarbis

Orient Overseas 2025 Rev $9.72B Vs. $10.70B >0316.HK

2026-03-12 22:13; UTC

Uždarbis

Orient Overseas 2025 Net $1.51B Vs. Net $2.58 >0316.HK

2026-03-12 22:13; UTC

Rinkos pokalbiai

Uždarbis

Global Equities Roundup: Market Talk

2026-03-12 22:13; UTC

Rinkos pokalbiai

Uždarbis

Adobe Says Customers Want to Try AI Products for Free First -- Market Talk

2026-03-12 21:16; UTC

Įsigijimai, susijungimai, perėmimai

Alexander & Baldwin: JV Formed by Affil of MW Group and Funds Affiliated With Blackstone and DivcoWest Completed Acquisition of All Outstanding A&B Common Shrs >ALEX

2026-03-12 21:04; UTC

Uždarbis

Adobe Earnings Beat Is Overshadowed by CEO Departure. The Stock Is Sliding. -- Barrons.com

2026-03-12 21:02; UTC

Uždarbis

Wheaton Precious Metals 4Q Adj EPS $1.22 >WPM

2026-03-12 21:02; UTC

Uždarbis

Wheaton Precious Metals 4Q Sales $865M >WPM

2026-03-12 21:02; UTC

Uždarbis

Wheaton Precious Metals 4Q Net $558.3M >WPM

2026-03-12 21:02; UTC

Uždarbis

Wheaton Precious Metals 4Q EPS $1.23 >WPM

2026-03-12 20:57; UTC

Rinkos pokalbiai

Svarbiausios naujienos

No Need For Canada Rate Increases Amid Jump in Bond Yields -- Market Talk

2026-03-12 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-03-12 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-03-12 20:15; UTC

Įsigijimai, susijungimai, perėmimai

Eaton Completes Acquisition Of Leading Liquid-cooling Solutions Provider Boyd Thermal, Creating An Industry-leading Grid-to-chip Solution For Data Centers >ETN

2026-03-12 20:10; UTC

Uždarbis

Adobe Sees 2Q Rev $6.43B-$6.48B >ADBE

2026-03-12 20:05; UTC

Uždarbis

Adobe 1Q Rev $6.4B >ADBE

2026-03-12 20:05; UTC

Uždarbis

Adobe Sees 2Q Adj EPS $5.80-Adj EPS $5.85 >ADBE

Akcijų palyginimas

Kainos pokytis

Ventyx Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

-4.43% į apačią

12 mėnesių prognozė

Vidutinis 13.38 USD -4.43%

Aukščiausias 14 USD

Žemiausias 9 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Ventyx Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

8 ratings

Pirkti

Laikyti

Parduoti

Remiantis 8 analitikų, pateikusių Ventyx Biosciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Apie bendrovę Ventyx Biosciences Inc

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.